Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

article

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJMOA0807986
P698PubMed publication ID19458363

P50authorMadhu K NatarajanQ89024080
David P FaxonQ114292261
Hans-Jürgen RupprechtQ114444128
Sanjit S JollyQ114453049
Salim YusufQ2214381
Petr WidimskýQ12045089
Philippe Gabriel StegQ16027739
Alvaro AvezumQ48865428
William E BodenQ60503412
Christopher B. GrangerQ62050240
Keith FoxQ72227369
Susan ChrolaviciusQ82040593
Jean-Pierre BassandQ82062172
Shamir MehtaQ87398837
P2093author name stringJun Zhu
Rizwan Afzal
Craig Horsman
Jacques Col
P433issue21
P407language of work or nameEnglishQ1860
P921main subjectacute coronary syndromeQ266018
P1104number of pages11
P304page(s)2165-2175
P577publication date2009-05-21
P1433published inThe New England Journal of MedicineQ582728
P1476titleEarly versus Delayed Invasive Intervention in Acute Coronary Syndromes
P478volume360

Reverse relations

cites work (P2860)
Q379654812011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician.
Q379538852011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi
Q222419222014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Q537967872014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease.
Q376475042015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
Q39952939A Dutch perspective on the ESC/EACTS guidelines on myocardial revascularisation
Q45896046A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial
Q48510946A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction
Q61450633A phase 1, first-in-human study of F-GP1 positron emission tomography for imaging acute arterial thrombosis
Q48206499A portable prototype magnetometer to differentiate ischemic and non-ischemic heart disease in patients with chest pain
Q92971778Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154 000 Individuals
Q37789014Acute coronary syndrome update for hospitalists
Q48659761Acute coronary syndrome. A diffuse diagnosis
Q38168182Acute coronary syndrome: optimising management through risk assessment
Q88960063Acute coronary syndromes
Q30490718Acute coronary syndromes: diagnosis and management, part I
Q37638627Acute coronary syndromes: selective vs early invasive strategies
Q48368949Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis
Q26783157Acute management of unstable angina and non-ST segment elevation myocardial infarction
Q30248576Acute myocardial infarction
Q38813299An update on management of the patient presenting with non-ST-elevation acute coronary syndromes
Q50864337Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".
Q58920107Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized Medicine
Q41265453Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome.
Q36714117Area Median Income and Metropolitan Versus Nonmetropolitan Location of Care for Acute Coronary Syndromes: A Complex Interaction of Social Determinants
Q24288920Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Q64924978Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.
Q26801639B Cells and Functional Antibody Responses to Combat Influenza
Q84544342Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI!
Q38059154Biomarkers in acute coronary artery disease
Q54624187Biomarkers in the triage of chest pain: are we making progress?
Q38423493Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?
Q46046218Cangrelor: a new CHAMPION for percutaneous coronary intervention
Q36911023Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome
Q42139860Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury
Q61807901Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015
Q40865080Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study
Q28383967Clinical outcome of veterans with acute coronary syndrome who had been exposed to agent orange
Q53644963Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization.
Q48186817Clinical presentation of patients with spontaneous coronary artery dissection.
Q33595369Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction
Q92564333Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis
Q90701411Comparison of enoxaparin and unfractionated heparin in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Q42853394Comparison of immediate vs early invasive strategy in patients with first acute non-ST-elevation myocardial infarction
Q35017307Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention
Q30575258Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry
Q42716722Composite risk scores for acute coronary syndromes
Q37765146Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).
Q50575232Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
Q36214892Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014.
Q37377798Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort
Q38049328Current state of the performance of percutaneous coronary intervention in centres without on-site cardiac surgery
Q48021754Danish trends in pharmacotherapy, comorbidities, and demographics in patients referred for coronary angiography: what changed during a decade?
Q38245287Decade in review--acute coronary syndromes: Successes and future objectives in acute coronary syndrome
Q92961510Derivation and Validation of a Novel Cardiac Intensive Care Unit Admission Risk Score for Mortality
Q38347336Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes: Clopidogrel, Prasugrel, and Ticagrelor
Q35017934Discrepancy between clinician and research assistant in TIMI score calculation (TRIAGED CPU)
Q47613575Discrimination of patients with type 2 myocardial infarction
Q36559522Does T wave inversion in lead aVL predict mid-segment left anterior descending lesions in acute coronary syndrome? A retrospective study
Q42917584Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Q38896245Early Invasive Strategy and In-Hospital Survival Among Diabetics With Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight.
Q36974390Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials
Q36319844Early diagnosis of acute myocardial infarction using high-sensitivity troponin I
Q44384417Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant?
Q40771637Early invasive versus early conservative strategy in non-ST-elevation acute coronary syndrome: An outcome research study.
Q44823803Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age.
Q48198112Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.
Q38001384Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials
Q47848413Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study
Q37832057Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies
Q53590491Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction.
Q37140992Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?
Q46810982Estimation of a decreasing hazard of patients with acute coronary syndrome
Q51731741Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial.
Q49887605Examination of the appropriate timing of reperfusion therapy for recent myocardial infarction: a Japanese single-center retrospective study
Q40793052Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients.
Q38647581GDF-15 predicts cardiovascular events in acute chest pain patients.
Q38602893Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review
Q88709430German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock
Q37942701Glycoprotein IIb-IIIa inhibitors
Q30486060High incidence of acute coronary occlusion in patients without protocol positive ST segment elevation referred to an open access primary angioplasty programme
Q98386250High sensitivity troponin measurement in critical care: Flattering to deceive or 'never means nothing'?
Q47772072High sensitivity troponins in contemporary cardiology practice: are we turning a corner?
Q36769832High-sensitive cardiac troponin T
Q93337831High-sensitivity cardiac troponin assays: finally ready for prime time?
Q37926596High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department
Q27007551High-sensitivity troponin assays: evidence, indications, and reasonable use
Q37448857Hospital length of stay in patients with non-ST-segment elevation myocardial infarction
Q35714803Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
Q47138841Immediate/Early vs. Delayed Invasive Strategy for Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review and Meta-Analysis
Q26774723Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 Studies
Q38683249Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer
Q64067114In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Interventi
Q41232859In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure.
Q43592490Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy
Q37481596Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes
Q39772400Inefficacy interim monitoring procedures in randomized clinical trials: the need to report
Q37399613Influence of the Timing of Percutaneous Coronary Intervention on Clinical Outcomes in Non-ST-Elevation Myocardial Infarction
Q47742517Is there a role for myocardial perfusion imaging in patients with an elevated high-sensitivity troponin?
Q85042544Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome
Q93208447Management of Acute Myocardial Infarction During the COVID-19 Pandemic
Q37984773Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment
Q39314230Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome
Q97524590Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine
Q66684648Mental health reform fails
Q42336179Merits of Invasive Strategy in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome
Q41725140Nationwide trends in use and timeliness of diagnostic coronary angiography in acute coronary syndromes from 2005 to 2011: Does distance to invasive heart centres matter?
Q35140435Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats
Q37041708Non-ST elevation myocardial infarction (NSTEMI) in three hospital settings in South Africa: does geography influence management and outcome? A retrospective cohort study
Q35026325Non-ST-elevation myocardial infarction in the United States: contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes
Q36185831Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification
Q36819302Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)
Q58812220Nurse-led Early Triage (NET) study of chest pain patients: a long term evaluation study of a service development aimed at improving the management of patients with non-ST-elevation acute coronary syndromes
Q90608191Optimal Timing of Invasive Coronary Angiography following NSTEMI
Q38640097Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.
Q37780031Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes
Q55204798Optimal treatment of patients with NSTE-ACS in the Dutch health care system.
Q50864248Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b
Q38542096P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use
Q47105918Patient perspectives on engagement in decision-making in early management of non-ST elevation acute coronary syndrome: a qualitative study.
Q37561885Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
Q37900509Percutaneous coronary interventions in facilities without cardiac surgery on site
Q37782048Periprocedural Myocardial Infarction: Review and Classification
Q64120111Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
Q57482922Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: Insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial
Q48096262Pre-hospital transthoracic echocardiography for early identification of non-ST-elevation myocardial infarction in patients with acute coronary syndrome.
Q40207226Prediction of Angiographic Extent of Coronary Artery Disease on the Basis of Clinical Risk Scores in Patients of Unstable Angina
Q44425116Prevalence and interventional outcomes of patients with resolution of ST-segment elevation between prehospital and in-hospital ECG.
Q53591620Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin.
Q37027861Reducing time to angiography and hospital stay for patients with high-risk non-ST-elevation acute coronary syndrome: retrospective analysis of a paramedic-activated direct access pathway
Q55496702Regional to tertiary inter-hospital transfer versus in-house percutaneous coronary intervention in acute coronary syndrome.
Q22241917Reperfusion Strategies in Acute Coronary Syndromes
Q99615004Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome
Q38009702Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?
Q26769732Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment
Q57482608Risk stratification in non-ST elevation acute coronary syndromes: searching for the right formula
Q26471900Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
Q37951403Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes.
Q37967491Routine invasive versus conservative management strategies in acute coronary syndrome: time for a "hybrid" approach
Q36116996SBC guidelines on unstable angina and non-ST-elevation myocardial infarction: executive summary
Q42942498STEMI or non-STEMI: that is the question
Q36988007Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers.
Q31003983Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network.
Q38097508Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome.
Q40571070Socio-economic position and time trends in invasive management and case fatality after acute myocardial infarction in Denmark
Q90094277Temporal Pattern of CABG and PCI after Non-ST Elevation Myocardial Infarction Among Elderly Patients from NHDS
Q61446637Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S
Q36367018The 2012 ACCF/AHA Focused Update of the Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Guideline: a critical appraisal
Q58696046The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the Treatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Tria
Q31086486The Relation between the Timing of Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome with Routine Invasive Strategy - Data from Taiwan Acute Coronary Syndrome Full Spectrum Data Registry.
Q50055934The Usefulness and Limitations of Point-of-care Cardiac Troponin Measurement in the Emergency Department
Q89912295The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain
Q58819403The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI
Q42320940The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: early invasive strategy for all?
Q37947959The management of thrombotic lesions in the cardiac catheterization laboratory
Q38171867The role of computed tomography in cardiovascular imaging: from X-ray department to emergency room.
Q84638957The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome
Q38375641Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
Q34441191Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients
Q38100602Timing of angiography in non-ST elevation myocardial infarction
Q50017162Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes.
Q37946393Timing of early invasive intervention in patients with moderate to high risk acute coronary syndromes
Q47106446Timing of invasive strategy in patients with non-ST-segment elevation acute coronary syndrome and effect on clinical outcomes.
Q50017119Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study
Q88687563Timing of revascularisation for acute coronary syndrome
Q40206567Towards a reappraisal of the TACTICS TIMI 18 trial in the era of modern pharmacological and interventional therapies
Q47097300Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?
Q64284601Treatment patterns of non-ST-elevation acute coronary syndrome patients presenting at non-PCI centres in the Netherlands and possible logistical consequences of adopting same-day transfer to PCI centres: a registry-based evaluation
Q50732528Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003-2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR).
Q37517246Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark
Q35196125Troponin elevation in acute ischemic stroke (TRELAS)--protocol of a prospective observational trial
Q38837406Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome
Q37972109Unstable angina and non-ST elevation myocardial infarction
Q43133216Update on interventional cardiology
Q90471261Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry
Q37760095What goes into a major acute coronary syndrome trial and what will future trials look like?
Q28072343When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
Q88991681[Cardiac causes of chest pain]
Q86643067[ESC guidelines 2015. Non-ST-elevation acute coronary syndrome]
Q83179013[Ischemic heart disease: 2009 update]
Q82334758[The length of hospital stay in patients with acute coronary syndrome is reduced by establishing a chest pain unit]
Q87370707[Timing of invasive treatment in NSTEMI: as fast as in STEMI?]
Q83320619[Update in interventional cardiology]
Q268299732012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat
Q267747982015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteri
Q22242895ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Search more.